SDEV

Stablecoin Development Corp. AMEX

Healthcare ·Medical - Pharmaceuticals ·US · novabay.com

$1.43

Mkt Cap $38.1M

52w Low $1.20 24.7% of range 52w High $2.13

50d MA $1.95 200d MA $1.95

P/E (TTM) -0.2x

EV/EBITDA -0.0x

P/B —

Debt/Equity -0.0x

ROE 95.5%

P/FCF -0.9x

RSI (14) —

ATR (14) —

Beta 0.16

50d MA $1.95

200d MA $1.95

Avg Volume 454.1K

About

Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Recent Filings

8-K

Stablecoin Development Corporation -- 8-K Filing

Stablecoin Development Corporation's preferred stock conversion triggered anti-dilution provisions, increasing pre-funded warrant shares by approximately 22.7 million, potentially diluting existing shareholders upon exercise.

Apr 29

8-K

Unknown — 8-K Filing

SDEV's name change and ticker transition signal a strategic pivot toward blockchain protocol investments, potentially offering exposure to decentralized finance but introducing higher volatility and regulatory uncertainty that investors should carefully evaluate.

Apr 6

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

SDEV's significant expansion of its equity incentive pool to 32.9 million shares signals aggressive executive compensation plans, potentially diluting existing shareholders' ownership stakes substantially.